SP
BravenNow
Sitaram Siddharth sells Doximity shares worth $58,833
| USA | economy | ✓ Verified - investing.com

Sitaram Siddharth sells Doximity shares worth $58,833

Entity Intersection Graph

No entity connections available yet for this article.

}
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Wall Street ends deep in the red amid renewed spike in oil prices due to Iran war Oil prices jump after Iran says critical Strait of Hormuz to remain shut Gold prices slip as inflationary worries due to oil spike weighs on sentiment This chart could spell trouble for crypto and Bitcoin bulls 🧠 Upgrade to AI Insights (South Africa Philippines Nigeria) 🧠 Upgrade to AI Insights Sitaram Siddharth sells Doximity shares worth $58,833 By Insider Trading Published 03/12/2026, 09:24 PM Sitaram Siddharth sells Doximity shares worth $58,833 0 DOCS -1.46% Interim PFO and PAO of Doximity , Inc. (NASDAQ:DOCS), Sitaram Siddharth, sold 2,319 shares of Class A Common Stock on March 10, 2026, at a price of $25.37, totaling $58,833. The transaction was executed automatically pursuant to a Rule 10b5-1 trading plan.The sale comes as Doximity shares trade at $24.28, hovering just above their 52-week low of $23.53. According to InvestingPro analysis, the stock appears undervalued at current levels, with shares down 66% over the past six months. The company maintains impressive gross profit margins of nearly 90%, one of 12+ InvestingPro Tips available to subscribers. On the same day, Sitaram Siddharth also converted 5,000 shares of Class B Common Stock to Class A Common Stock. Additionally, 5,000 shares were acquired through the exercise of stock options with an exercise price of $4.12. In other recent news, Doximity Inc reported its fiscal third-quarter results, revealing revenue and EBITDA that exceeded guidance and consensus by $4.6 million and $7.9 million, respectively. This positive financial performance comes amid various analyst actions concerning the company’s stock. Canaccord Genuity upgraded Doximity to a Buy rating, citing valuation, although it lowered its price target from $48.00 to $34.00, considering recent market reactions. Meanwhile, Piper Sandler raised its price target to $42, maintaining an Overweight rating a...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine